3rd. Circ. Reverses GSK Win In Avandia Marketing Suit

The Third Circuit ruled in a precedential opinion Tuesday that a Pennsylvania federal judge erred on several grounds in granting summary judgment to GlaxoSmithKline in a lawsuit over the marketing of the diabetes drug Avandia…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s